While the function of C/EBPβ in glioma progression is less defined, STAT3 has a well-characterized role in cancer progression and its activation in GBM is associated with the aggressive mesenchymal subtype and poor overall survival [33, 44, 45]. Here, CEBPB is linked to glioblastoma.